Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1

被引:45
作者
Ataga, Kenneth I. [1 ,2 ]
Brittain, Julia E. [2 ,3 ]
Moore, Dominic [4 ]
Jones, Susan K. [1 ,2 ]
Hulkower, Ben [2 ]
Strayhorn, Dell [1 ,2 ]
Adam, Soheir [1 ,2 ]
Redding-Lallinger, Rupa [2 ,5 ]
Nachman, Patrick [6 ]
Orringer, Eugene P. [1 ,2 ]
机构
[1] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Comprehens Sickle Cell Program, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC 27599 USA
关键词
hemophilia A; mutations; structure-function; factor VIII; GROWTH-FACTOR RECEPTOR; 3RD NATIONAL-HEALTH; RISK-FACTORS; RENAL-FUNCTION; CHILDREN; MICROALBUMINURIA; ADULTS; PREVALENCE; FAILURE; ANEMIA;
D O I
10.1111/j.1600-0609.2010.01471.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hemophilia A (HA) is a common X-linked recessive bleeding disease caused by mutations in FVIII gene. The identification of mutation in HA subjects can lead to more accurate diagnosis and contribute to the genetic counseling/prenatal diagnosis. Objectives: Our objective is to identify the FVIII defects in 148 unrelated Chinese HA subjects and to analyze the potential consequence of novel mutations. Methods: FVIII: C was assayed using one-stage method, and FVIII inhibitor was tested using Bethesda method. Intron 22 and 1 inversions were identified by PCR technique. Non-inversion mutations of FVIII gene were identified by direct sequencing. Novel mutations were further analyzed based on a B-domain deleted FVIII crystallographic structure and bioinformatics tools. Results: The intron 22 and 1 inversions affected 57 and three severe subjects, respectively. Sixty-seven different mutations were identified in non-inversion subjects including 35 novel mutations that were not reported previously. Novel mutations include five nonsense mutations, 15 missense mutations, three insertions, eight small deletions, two splice site mutations and two partial gene deletions. The potential deleterious effects of these novel missense mutations include disruption of the protein core, impairment of inter-domain interaction and FVIII binding with other proteins. Conclusion: Similar to other races, intron 22 and one inversions are also recurrent mutation in severe HA subjects monitored in our centre. Sixty-seven mutations (52% novel reported) among 88 non-inversion subjects represent the high degree of heterogeneity of FVIII gene mutations causing HA. Characteristic of HA FVIII gene mutations extend our insight into structure-function relationship of the FVIII molecule.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 38 条
  • [21] Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
    Kato, Gregory J.
    Gladwin, Mark T.
    Steinberg, Martin H.
    [J]. BLOOD REVIEWS, 2007, 21 (01) : 37 - 47
  • [22] Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
    Kim, NH
    Oh, JH
    Seo, JA
    Lee, KW
    Kim, SG
    Choi, KM
    Baik, SH
    Choi, DS
    Kang, YS
    Han, SY
    Han, KH
    Ji, YH
    Cha, DR
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (01) : 167 - 177
  • [23] Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
    Koga, K
    Osuga, Y
    Yoshino, O
    Hirota, Y
    Xie, RM
    Hirata, T
    Takeda, S
    Yano, T
    Tsutsumi, O
    Taketani, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) : 2348 - 2351
  • [24] Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease
    Landburg, P. P.
    Elsenga, H.
    Schnog, B.
    Duits, A. J.
    [J]. ACTA HAEMATOLOGICA, 2008, 120 (03) : 130 - 133
  • [25] N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease
    Machado, Roberto F.
    Anthi, Anastasia
    Steinberg, Martin H.
    Bonds, Duane
    Sachdev, Vandana
    Kato, Gregory J.
    Taveira-DaSilva, Angelo M.
    Ballas, Samir K.
    Blackwelder, William
    Xu, Xiuli
    Hunter, Lori
    Barton, Bruce
    Waclawiw, Myron
    Castro, Oswaldo
    Gladwin, Mark T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (03): : 310 - 318
  • [26] Risk factors for microalbuminuria in children with sickle cell anemia
    McBurney, PG
    Hanevold, CD
    Hernandez, CM
    Waller, JL
    McKie, KM
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (06) : 473 - 477
  • [27] Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease
    McKie, Kathleen T.
    Hanevold, Coral D.
    Hernandez, Caterina
    Waller, Jennifer L.
    Ortiz, Luis
    McKie, Kathleen M.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (03) : 140 - 144
  • [28] Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects
    McQuillan, BM
    Picard, MH
    Leavitt, M
    Weyman, AE
    [J]. CIRCULATION, 2001, 104 (23) : 2797 - 2802
  • [29] Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease
    Niu, Xiaomei
    Nouraie, Mehdi
    Campbell, Andrew
    Rana, Sohail
    Minniti, Caterina P.
    Sable, Craig
    Darbari, Deepika
    Dham, Niti
    Reading, N. Scott
    Prchal, Josef T.
    Kato, Gregory J.
    Gladwin, Mark T.
    Castro, Oswaldo L.
    Gordeuk, Victor R.
    [J]. PLOS ONE, 2009, 4 (11):
  • [30] Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1α
    Patel, Nitin
    Gonsalves, Caryn S.
    Malik, Punam
    Kalra, Vijay K.
    [J]. BLOOD, 2008, 112 (03) : 856 - 865